electroCore to Announce Fourth Quarter and Year Ended December 31, 2020 Financial Results on Thursday, March 11

Rhea-AI Summary

electroCore (Nasdaq: ECOR) will announce its financial results for Q4 and the fiscal year ending December 31, 2020, after market close on March 11, 2021. A conference call is scheduled for 4:30 PM ET for management to discuss the results. The company focuses on bioelectronic medicine, particularly through non-invasive vagus nerve stimulation therapy, addressing conditions such as cluster headaches and migraines in adults and adolescents.

Positive

• Scheduled announcement of financial results may provide clarity on company performance.
• Focus on bioelectronic medicine indicates a niche market with potential for growth.

Negative

• None.

Conference Call to be Held at 4:30pm Eastern Time

ROCKAWAY, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the fourth quarter and year ended December 31, 2020 after the close of the market on Thursday, March 11, 2021. Management will host a conference call and webcast at 4:30pm Eastern Time to discuss the financial results and answer questions.

Thursday, March 11 @ 4:30pm Eastern Time
Domestic:	877-407-4018
International:	201-689-8471
Conference ID:	13715729
Webcast:	http://public.viavid.com/index.php?id=143276

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, and the acute and preventive treatment of migraine in adolescent (ages 12 and older) and adult patients.

For more information, visit www.electrocore.com.

Investors:
Hans Vitzthum
LifeSci Advisors
617-430-7578
hans@lifesciadvisors.com

or

Media Contact:
Summer Diaz
electroCore
973-290-0097
summer.diaz@electrocore.com

FAQ

When will electroCore report its financial results?

electroCore will report its financial results on March 11, 2021, after market close.

What time is the electroCore conference call?

The conference call is scheduled for 4:30 PM Eastern Time on March 11, 2021.

What conditions does electroCore focus on treating?

electroCore focuses on treating cluster headaches and migraines through bioelectronic medicine.

What is the ticker symbol for electroCore?

The ticker symbol for electroCore is ECOR.